$XBIT News

XBiotech Q1 EPS $(0.18) Up From $(0.36) YoY

XBiotech: Q4 Earnings Snapshot

XBiotech Announces John Simard To Retire As CEO, To Continue As Chairman; Sushma Shivaswamy Appointed Interim CEO

XBiotech Q3 EPS $(0.20) Down From $(0.16) YoY

XBiotech: Q3 Earnings Snapshot

XBiotech Inc.'s (NASDAQ:XBIT) top owners are retail investors with 52% stake, while 36% is held by insiders

XBiotech: Q2 Earnings Snapshot

XBiotech Q2 EPS $(0.06) Up From $(0.43) YoY

Here's Why We're Not Too Worried About XBiotech's (NASDAQ:XBIT) Cash Burn Situation

XBiotech: Q1 Earnings Snapshot

XBiotech Inc.'s (NASDAQ:XBIT) largest shareholders are individual investors with 49% ownership, insiders own 35%

XBiotech Pauses Rheumatology program

XBiotech: Q2 Earnings Snapshot

XBIT Stock Earnings: XBiotech Reported Results for Q2 2024

XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for Advanced Pancreatic Cancer

XBiotech trading resumes

XBiotech announces data from Phase 1/2 1-BETTER study

XBiotech trading halted, volatility trading pause

XBiotech: Several Shots On Goal In Big Target Market Indications